{"title":"The Effect of Laughter Yoga on Chemotherapy-Induced Symptoms and Sleep Quality in Patients with Haematologic Cancer.","authors":"Ozlem Ugur, Gulsah Bedez, Solmaz Zeybekci, Ezgi Karadag","doi":"10.31557/APJCP.2025.26.6.1959","DOIUrl":null,"url":null,"abstract":"<p><p>There are international studies that examine the effects of laughter yoga on the symptoms and quality of life of cancer patients as a complementary therapeutic method.</p><p><strong>Aim: </strong>This study aims to examine the effect of laughter yoga on chemotherapy-induced symptoms and sleep quality in patients with haematologic cancer.</p><p><strong>Materials and methods: </strong>This study was conducted as a randomised controlled trial with two parallel treatment arms. The study was between November 2020 and December 2021. The sample was calculated with 60 patients including in the study. A total of 4 sessions of laughter yoga were applied in the experimental group for 45 minutes twice a week for two weeks. No intervention was applied to the control group; clinical routine care continued.</p><p><strong>Results: </strong>Pittsburgh Sleep Quality Index scores was analysed, a statistically significant difference was found between the scores of the intervention and control groups in the subjective sleep quality component. A significant difference was found between the scores of the intervention group in the sleep duration and sleep disturbances components. Based on the results from the Edmonton Symptom Assessment System, a statistically significant difference was found in the scores of pain and anxiety components in the intervention group, in the scores of tiredness/nausea/depression/drowsiness/appetite/well-being components in the intervention and control groups.</p><p><strong>Conclusion: </strong>A significant difference was found in the scores of the pain and anxiety components in the intervention group. It was also found that the scores of the sleep duration and sleep disturbances components in the intervention group were better than the control group.</p>","PeriodicalId":55451,"journal":{"name":"Asian Pacific Journal of Cancer Prevention","volume":"26 6","pages":"1959-1970"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31557/APJCP.2025.26.6.1959","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
There are international studies that examine the effects of laughter yoga on the symptoms and quality of life of cancer patients as a complementary therapeutic method.
Aim: This study aims to examine the effect of laughter yoga on chemotherapy-induced symptoms and sleep quality in patients with haematologic cancer.
Materials and methods: This study was conducted as a randomised controlled trial with two parallel treatment arms. The study was between November 2020 and December 2021. The sample was calculated with 60 patients including in the study. A total of 4 sessions of laughter yoga were applied in the experimental group for 45 minutes twice a week for two weeks. No intervention was applied to the control group; clinical routine care continued.
Results: Pittsburgh Sleep Quality Index scores was analysed, a statistically significant difference was found between the scores of the intervention and control groups in the subjective sleep quality component. A significant difference was found between the scores of the intervention group in the sleep duration and sleep disturbances components. Based on the results from the Edmonton Symptom Assessment System, a statistically significant difference was found in the scores of pain and anxiety components in the intervention group, in the scores of tiredness/nausea/depression/drowsiness/appetite/well-being components in the intervention and control groups.
Conclusion: A significant difference was found in the scores of the pain and anxiety components in the intervention group. It was also found that the scores of the sleep duration and sleep disturbances components in the intervention group were better than the control group.
期刊介绍：
Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation.
The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally.
The APJCP publishes original research results under the following categories:
-Epidemiology, detection and screening.
-Cellular research and bio-markers.
-Identification of bio-targets and agents with novel mechanisms of action.
-Optimal clinical use of existing anti-cancer agents, including combination therapies.
-Radiation and surgery.
-Palliative care.
-Patient adherence, quality of life, satisfaction.
-Health economic evaluations.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
